Key Highlights

  • Aeluma reported fourth quarter Revenue of 582,000 dollars, slightly ahead of estimates, with full fiscal 2026 revenue of 4.5 million dollars roughly flat year over year.
  • The company ended the year with 56 million dollars in cash and no Debt after raising 20.1 million dollars through its at-the-market Equity Facility during the quarter.
  • Aeluma is shifting focus from early-stage government research funding toward commercial photonics contracts tied to the AI datacenter buildout.
  • A letter of intent with the Department of Commerce CHIPS office could bring up to 30 million dollars in funding, likely structured as a government equity Investment rather than revenue.

Financial results amid a strategic transition

Aeluma, Inc. (NASDAQ:ALMU), a Goleta, California-based semiconductor company developing photonics components for AI data centers, reported fourth quarter fiscal 2026 revenue of 582,000 dollars, narrowly ahead of the 575,000 dollar consensus estimate. Full fiscal year revenue reached 4.5 million dollars, approximately flat compared with 4.7 million dollars in fiscal 2025, reflecting revenue that remains largely tied to government research contracts even as the company pivots toward commercial customers.

The company's GAAP net loss widened to 9.2 million dollars for the fiscal year, or 52 cents per share, compared with a 3 million dollar loss in the prior year, driven primarily by increased headcount and operating expenses as Aeluma scaled its team from 14 employees to more than 30. Adjusted EBITDA was negative 5.2 million dollars for the year, compared with positive 186,000 dollars in fiscal 2025, reflecting the cost of building out commercialization infrastructure ahead of anticipated revenue growth.

Positioning for the AI datacom buildout

Aeluma's strategic emphasis is increasingly centered on its Lynx family of high-speed photodetectors and Quasar quantum dot lasers, both built on non-indium phosphide substrates intended to address Supply constraints facing traditional photonics manufacturers. Management noted that industry-wide indium phosphide shortages, combined with the scale of anticipated AI Data Center capital expenditures, projected by Dell'Oro Group to reach 1.8 trillion dollars by 2030, are creating Demand for alternative substrate approaches that can scale to higher production volumes.

During the quarter, Aeluma strengthened its Manufacturing relationship with Sumitomo Chemical Advanced Technologies to expand wafer production capacity and announced a letter of intent with the Department of Commerce's CHIPS Research and Development office for funding of up to 30 million dollars. Management indicated this funding, if finalized, would likely be structured as a government equity investment rather than contract revenue, differentiating it from the company's historical Department of Defense and NASA-funded research programs. The company is also procuring additional MOCVD reactor systems to expand production capacity ahead of expected commercial demand.

Weighing commercial promise against execution timelines

The opportunity in front of Aeluma is substantial if commercial engagements with data center customers mature as management anticipates. The company disclosed it is negotiating several multi-million dollar non-recurring engineering agreements with prospective customers, and any conversion of these discussions into signed contracts during fiscal 2027 could meaningfully change the company's revenue trajectory from its current government-contract-dependent base.

However, the timeline for this transition carries real uncertainty. Management explicitly declined to provide formal revenue guidance for fiscal 2027 beyond 2.3 million dollars in already booked government contracts, citing the unpredictable timing of commercial contract conversion. Planned capital expenditures of 10 million to 12 million dollars for new manufacturing tools will likely keep near-term losses elevated, and the CHIPS funding remains subject to finalized definitive agreements that have not yet been completed.

A commercialization bet still in early innings

Aeluma's fourth quarter results reflect a company in the midst of a deliberate transition from government-funded research toward commercial AI datacom revenue, a shift that has widened near-term losses while strengthening its Balance Sheet and manufacturing capacity. The scale of the AI infrastructure buildout could provide substantial tailwinds if Aeluma's non-indium phosphide platform gains traction with data center customers. Whether the current pipeline of discussions converts into material revenue within the next several quarters remains the central variable for investors to watch.